tiprankstipranks
Advertisement
Advertisement

GB:POLB Stock Latest News

Poolbeg wins first cancer CRS patent for POLB 001 in Australia
Company AnnouncementsPoolbeg wins first cancer CRS patent for POLB 001 in Australia
13d ago
Poolbeg Pharma adds CAR-T veteran Kilcoyne to advisory board to bolster POLB 001 push
PremiumCompany Announcements
Poolbeg Pharma adds CAR-T veteran Kilcoyne to advisory board to bolster POLB 001 push
1M ago
Poolbeg Pharma bolsters case for POLB 001 with positive peer‑reviewed trial data
PremiumCompany Announcements
Poolbeg Pharma bolsters case for POLB 001 with positive peer‑reviewed trial data
2M ago
Poolbeg Pharma Increases Share Capital After Option Exercises
PremiumCompany Announcements
Poolbeg Pharma Increases Share Capital After Option Exercises
3M ago
Poolbeg Pharma Anticipates Clinical Breakthroughs Following a Year of Progress in 2025
PremiumCompany Announcements
Poolbeg Pharma Anticipates Clinical Breakthroughs Following a Year of Progress in 2025
4M ago
Poolbeg Pharma Leads in Groundbreaking Cancer Immunotherapy Research
PremiumCompany AnnouncementsPoolbeg Pharma Leads in Groundbreaking Cancer Immunotherapy Research
4M ago
Poolbeg Pharma Secures European Patent for POLB 001
Premium
Company Announcements
Poolbeg Pharma Secures European Patent for POLB 001
5M ago
Poolbeg Pharma Reports Strong Interim Results and Advances Key Clinical Trials
Premium
Company Announcements
Poolbeg Pharma Reports Strong Interim Results and Advances Key Clinical Trials
7M ago
Poolbeg Pharma Advances POLB 001 Trial with Key Partnership and Drug Supply
PremiumCompany Announcements
Poolbeg Pharma Advances POLB 001 Trial with Key Partnership and Drug Supply
7M ago
Poolbeg Pharma Announces Change in Voting Rights Structure
PremiumCompany Announcements
Poolbeg Pharma Announces Change in Voting Rights Structure
10M ago
Roaring Waters Capital Acquires 5.74% Stake in Poolbeg Pharma
PremiumCompany Announcements
Roaring Waters Capital Acquires 5.74% Stake in Poolbeg Pharma
10M ago
Poolbeg Pharma’s Executive Chair Increases Stake in Fundraising Effort
PremiumCompany Announcements
Poolbeg Pharma’s Executive Chair Increases Stake in Fundraising Effort
10M ago
Poolbeg Pharma Secures Shareholder Approval and Expands Capital
PremiumCompany AnnouncementsPoolbeg Pharma Secures Shareholder Approval and Expands Capital
10M ago
Poolbeg Pharma’s POLB 001 Receives FDA Orphan Drug Designation
Premium
Company Announcements
Poolbeg Pharma’s POLB 001 Receives FDA Orphan Drug Designation
11M ago
Poolbeg Pharma Releases Annual Report and Announces Fundraising Initiative
Premium
Company Announcements
Poolbeg Pharma Releases Annual Report and Announces Fundraising Initiative
11M ago
Poolbeg Pharma Raises £4.865 Million to Advance Clinical Trials
PremiumCompany Announcements
Poolbeg Pharma Raises £4.865 Million to Advance Clinical Trials
11M ago
Poolbeg Pharma Expands BookBuild Offer Amid Strong Demand
PremiumCompany Announcements
Poolbeg Pharma Expands BookBuild Offer Amid Strong Demand
11M ago
Poolbeg Pharma Raises £4.715 Million to Advance Clinical Trials
PremiumCompany Announcements
Poolbeg Pharma Raises £4.715 Million to Advance Clinical Trials
11M ago
Poolbeg Pharma Announces £4.1 Million Fundraising to Advance Clinical Trials
PremiumCompany Announcements
Poolbeg Pharma Announces £4.1 Million Fundraising to Advance Clinical Trials
11M ago
Poolbeg Pharma Launches £100,000 Retail Offer to Advance Key Trials
PremiumCompany AnnouncementsPoolbeg Pharma Launches £100,000 Retail Offer to Advance Key Trials
11M ago
Poolbeg Pharma Reports 2024 Results, Highlights Key Pipeline Advancements
Premium
Company Announcements
Poolbeg Pharma Reports 2024 Results, Highlights Key Pipeline Advancements
11M ago
Poolbeg Pharma to Showcase Innovations at Key Industry Conferences
Premium
Company Announcements
Poolbeg Pharma to Showcase Innovations at Key Industry Conferences
1y ago

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >